Boric Acid

Boric Acid

SCHEMBL3479728

CCCCN(CCCC)CCOCC(O)CO.OB(O)O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.57
HTT P42858 1/20 0.40
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
DUSP3 P51452 1/20 0.37
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.36
PLA2G2C Q5R387 1/20 0.36
LPAR5 Q9H1C0 1/20 0.36
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SPHK1 Q9NYA1 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
DGKA P23743 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5691789 0.95 USP2 (0.62) USP2HTTKDM4EMEN1KMT2A
SCHEMBL5691798 0.79 USP2 (0.37) USP2SPHK1
Glycerin SCHEMBL3479730 0.78 USP2 (0.35) USP2KDM4EMEN1KMT2ADUSP3
SCHEMBL4594915 0.77 USP2 (0.46) USP2LMNAHSD17B10CYP1A2
SCHEMBL8242073 0.77 USP2 (0.84) USP2HTTKDM4EMEN1KMT2A
SCHEMBL115795 0.77 USP2 (0.84) USP2HTTKDM4EMEN1KMT2A
SCHEMBL8503207 0.77 USP2 (0.84) USP2HTTKDM4EMEN1KMT2A
SCHEMBL11158 0.75 USP2 (0.96) USP2HTTKDM4EMEN1KMT2A
SCHEMBL5527804 0.75 USP2 (0.96) USP2HTTKDM4EMEN1KMT2A
SCHEMBL11294392 0.75 USP2 (0.96) USP2HTTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1310532-B1 Phase change inks containing borate esters XEROX CORP (US) 2006-05-17 EP claimed
US-6682591-B2 HYDROLYTICALLY STABLE XEROX CORPORATION 2004-01-27 US claimed
US-20030127020-A1 Aqueous ink compositions containing borate esters XEROX CORPORATION 2003-07-10 US claimed
US-6585816-B1 As vehicle for thermal ink jet printing; nonevaporating, nonspilling XEROX CORPORATION 2003-07-01 US claimed
EP-1310532-A1 Phase change inks containing borate esters Xerox Corporation (US) 2003-05-14 EP claimed
US-9028768-B2 Metal alkoxides, apparatus for manufacturing metal alkoxides, related methods and uses thereof AUTERRA, INC. (US) 2015-05-12 US disclosed
US-8877131-B2 Metal alkoxides, apparatus for manufacturing metal alkoxides, related methods and uses thereof AUTERRA, INC. (US) 2014-11-04 US disclosed
US-8262867-B2 Metal alkoxides, apparatus for manufacturing metal alkoxides, related methods and uses thereof AUTERRA, INC. (US) 2012-09-11 US disclosed
EP-2217387-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF Auterra, Inc. (US) 2010-08-18 EP disclosed
US-20100178218-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF AUTERRA, INC. (US) 2010-07-15 US disclosed
US-20100178220-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF AUTERRA, INC. (US) 2010-07-15 US disclosed
US-20100179339-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF AUTERRA, INC. (US) 2010-07-15 US disclosed
WO-2009070420-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF APPLIED NANOWORKS, INC. (US) 2009-06-04 WO disclosed
US-20090134369-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF APPLIED NANOWORKS, INC. (US) 2009-05-28 US disclosed
EP-1310532-B1 Phase change inks containing borate esters XEROX CORP (US) 2006-05-17 EP disclosed
US-6682591-B2 HYDROLYTICALLY STABLE XEROX CORPORATION 2004-01-27 US disclosed
US-20030127020-A1 Aqueous ink compositions containing borate esters XEROX CORPORATION 2003-07-10 US disclosed
US-6585816-B1 As vehicle for thermal ink jet printing; nonevaporating, nonspilling XEROX CORPORATION 2003-07-01 US disclosed
EP-1310532-A1 Phase change inks containing borate esters Xerox Corporation (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179339-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF ADH1A, AKR7A2, PAOX USP2 2341/4885HTT 3820/4885KDM4E 825/4885
US-20090134369-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF ADH1A, AKR7A2, PAOX USP2 2341/4885HTT 3820/4885KDM4E 825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.